North America Superdisintegrants Market to 2027 - Regional Analysis and Forecasts by Type (Synthetic Superdisintegrants, Natural Superdisintegrants, Other Superdisintegrants); Formulation (Tablets, Capsules); Therapeutic Area (Neurological Diseases, Gastrointestinal Diseases, Oncology, Inflammatory Diseases, Infectious Diseases, Cardiovascular Diseases, Other Diseases), and Country
North America, the superdisintegrants market, is anticipated to reach US$ 248.18 Mn in 2027 from US$ 136.37 Mn in 2019. The market is projected to grow with a CAGR of 7.9% from 2020-2027.
The rise of the superdisintegrants market is driven by factors such as the increasing prevalence of neurological diseases and benefits offered by generic drugs are boosting the market over the years. Although, pricing pressure on drug manufacturers is likely to hinder the growth of the market in the future years.
The region is witnessing exponential growth in the prevalence of chronic diseases. Factors such as the progression of viruses, bacteria, parasites, coupled with the growing adoption of a sedentary lifestyle, genetic conditions, and consumption of poor diet, are responsible for the increasing prevalence of these diseases. Also, oral drug delivery remains the most common route of drug administration in the healthcare world. Solid dosage forms typically include tablets, capsules, and powders for the treatment of particular disease conditions. Moreover, the growing emphasis on novel drug delivery approach is expected to boost awareness and focus on the utilization of orally disintegrating tablets during the forecast period. Superdisintegrants or orally disintegrating tablets are gaining traction due to advantages such as ease of drug administration and better compliance for pediatric and geriatric patients.
Furthermore, superdisintegrant tablets offer several benefits over traditional capsules and tablets. Advantages of disintegrants include an ability for accurate dosing, fast action, superior patient compliance, better palatability, and cost-effectiveness, as well as ease of administration, no risk of airway suffocation during swallowing, and flexibility in terms of large and small molecules. Such salient features of superdisintegrant tablets represent a massive potential for its adoption during tablet formulations. Thus, owing to the above-mentioned factors, the demand for superdisintegrants is increasing, which is anticipated to grow the market in the coming years.
In 2019, the US accounted for the largest market share in North America superdisintegrants market, and it is also expected to grow at a faster pace over the forecast period. US is an economically advanced country, and the country has the presence of various players that are well established in the pharmaceutical market. The companies are engaged in the research and development activities that are enabling them to develop the latest drugs for the diseases. Hence, considering the mentioned factors, the superdisintegrants market is expected to grow at a significant pace in the US during the forecast period.
US Superdisintegrants Market Revenue and Forecasts to 2027 (US$ Mn)
Get more information on this report :
NORTH AMERICA COLORECTAL CANCER – MARKET SEGMENTATION
North America Colorectal Cancer Market - By Type
- Synthetic Superdisintegrants
- Crospovidone
- Modified Starch
- Modified Cellulose
- Calcium Silicates
- Ion Exchange Resins
- Natural Superdisintegrants
- Other Superdisintegrants
North America Colorectal Cancer Market - By Formulation
- Tablets
- Capsules
North America Colorectal Cancer Market - By Therapeutic Area
- Neurological Diseases
- Gastrointestinal Diseases
- Oncology
- Inflammatory Diseases
- Infectious Diseases
- Cardiovascular Diseases
- Other Diseases
North America Colorectal Cancer Market - By Geography
- North America
- US
- Canada
- Mexico
Company Profiles
- Ashland,
- BASF SE
- DowDupont Inc.
- JRS PHARMA
- COREL PHARMA CHEM
- Roquette Frères
- Asahi Kasei Corporation
- Merck KGaA
- Avantor, Inc.
- DFE Pharma
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 North America Superdisintegrants Market – By Type
1.3.2 North America Superdisintegrants Market – By Formulation
1.3.3 North America Superdisintegrants Market – By Therapeutic Area
1.3.4 North America Superdisintegrants Market – By Country
2. North America Superdisintegrants Market– Key Takeaways
2.1 Coverage
2.2 Secondary Research
2.3 Primary Research
3. North America Superdisintegrants Market – Market Landscape
3.1 Overview
3.2 PEST Analysis
3.2.1 Superdisintegrants Market - North America Pest Analysis
3.3 Expert Opinion
4. North America Superdisintegrants Market - Key Market Dynamics
4.1 Key Market Drivers
4.1.1 Increasing Prevalence Of Neurological Diseases
4.1.2 Increasing Acceptability of Generic Drugs
4.2 Key Restraints
4.2.1 Pricing Pressure On Drug Manufacturers
4.3 Key Market Opportunities
4.3.1 Growing Medical Tourism In Mexico
4.4 Future Trend
4.4.1 Inclination Towards Personalized Medicine
4.5 Impact Analysis
5. Superdisintegrants Market – North America Analysis
5.1 North America Superdisintegrants Market Revenue Forecasts and Analysis
5.2 Positioning Of Key Players
6. North America Superdisintegrants Market Analysis And Forecasts To 2027 – Type
6.1 Overview
6.2 North America Superdisintegrants Market, By Type 2019 & 2027 (%)
6.2.1 North America Superdisintegrants Market, Revenue And Forecast To 2027, By Type (US$ Mn)
6.2.1.1 North America Synthetic Superdisintegrants Market, Revenue And Forecast To 2027, By Type (US$ Mn)
6.3 Synthetic Superdisintegrants
6.3.1 Overview
6.3.2 North America Synthetic Superdisintegrants Market Revenue And Forecast To 2027 (US$ Mn)
6.3.2.1 Crospovidone Market
6.3.2.1.1 Overview
6.3.2.1.2 North America Crospovidone Market Revenue and Forecast to 2027 (US$ Mn)
6.3.2.2 Modified Starch Market
6.3.2.2.1 Overview
6.3.2.2.2 North America Modified Starch Market Revenue and Forecast to 2027 (US$ Mn)
6.3.2.3 Modified Cellulose Market
6.3.2.3.1 Overview
6.3.2.3.2 North America Modified Cellulose Market Revenue and Forecast to 2027 (US$ Mn)
6.3.2.4 Calcium Silicates Market
6.3.2.4.1 Overview
6.3.2.4.2 North America Calcium Silicates Market Revenue and Forecast to 2027 (US$ Mn)
6.3.2.5 Ion Exchange Resins Market
6.3.2.5.1 Overview
6.3.2.5.2 North America Ion Exchange Resins Market Revenue and Forecast to 2027 (US$ Mn)
6.4 Natural Superdisintegrants
6.4.1 Overview
6.4.2 North America Natural Superdisintegrants Market Revenue And Forecast To 2027 (US$ Mn)
6.5 Other Superdisintegrants
6.5.1 Overview
6.5.2 North America Other Superdisintegrants Market Revenue And Forecast To 2027 (US$ Mn)
7. North America Superdisintegrants Market Analysis– By Formulation
7.1 Overview
7.2 North America Superdisintegrants Market, By Formulation 2019 & 2027 (%)
7.2.1 North America Superdisintegrants Market, Revenue and Forecast to 2027, by Formulation (US$ Mn)
7.3 Tablets
7.3.1 Overview
7.3.2 North America Tablets Market Revenue and Forecast to 2027 (US$ Mn)
7.4 Capsules
7.4.1 Overview
7.4.2 North America Capsules Market Revenue and Forecast to 2027 (US$ Mn)
8. North America Superdisintegrants Market Analysis– By Therapeutic Area
8.1 Overview
8.2 North America Superdisintegrants Market, By Therapeutic Area 2019 & 2027 (%)
8.2.1 North America Superdisintegrants Market, Revenue and Forecast to 2027, By Therapeutic Area (US$ Mn)
8.3 Neurological Diseases
8.3.1 Overview
8.3.2 North America Neurological Diseases Market Revenue and Forecast to 2027 (US$ Mn)
8.4 Gastrointestinal Diseases
8.4.1 Overview
8.4.2 North America Gastrointestinal Diseases Market Revenue and Forecast to 2027 (US$ Mn)
8.5 Oncology
8.5.1 Overview
8.5.2 North America Oncology Market Revenue and Forecast to 2027 (US$ Mn)
8.6 Inflammatory Diseases
8.6.1 Overview
8.6.2 North America Inflammatory Diseases Market Revenue and Forecast to 2027 (US$ Mn)
8.7 Infectious Diseases
8.7.1 Overview
8.7.2 North America Infectious Diseases Market Revenue and Forecast to 2027 (US$ Mn)
8.8 Cardiovascular Diseases
8.8.1 Overview
8.8.2 North America Cardiovascular Diseases Market Revenue and Forecast to 2027 (US$ Mn)
8.9 Others
8.9.1 Overview
8.9.2 North America Others Market Revenue and Forecast to 2027 (US$ Mn)
9. Superdisintegrants Market Revenue And Forecasts To 2027 – Geographical Analysis
9.1 North America Superdisintegrants Market Revenue and Forecasts To 2027
9.1.1 Overview
9.1.2 North America Superdisintegrants Market, Revenue and Forecast to 2027 (US$ Mn)
9.1.3 North America Superdisintegrants Market, Revenue and Forecast to 2027, by Type (US$ Mn)
9.1.3.1 North America Synthetic Superdisintegrants Market, Revenue and Forecast to 2027, by Type (US$ Mn)
9.1.4 North America Superdisintegrants Market, Revenue and Forecast to 2027, by Formulation (US$ Mn)
9.1.5 North America Superdisintegrants Market, Revenue and Forecast to 2027, By Therapeutic Area (US$ Mn)
9.1.6 North America Superdisintegrants Market, Revenue and Forecast to 2027, By Country (%)
9.1.7 US
9.1.7.1 US Superdisintegrants Market, Revenue and Forecast to 2027 (US$ Mn)
9.1.7.2 US Superdisintegrants Market, Revenue and Forecast to 2027, by Type (US$ Mn)
9.1.7.2.1 US Synthetic Superdisintegrants Market, Revenue and Forecast to 2027, by Type (US$ Mn)
9.1.7.3 US Superdisintegrants Market, Revenue and Forecast to 2027, by Formulation (US$ Mn)
9.1.7.4 US Superdisintegrants Market, Revenue and Forecast to 2027, By Therapeutic Area (US$ Mn)
9.1.8 Canada
9.1.8.1 Canada Superdisintegrants Market, Revenue and Forecast to 2027 (US$ Mn)
9.1.8.2 Canada Superdisintegrants Market, Revenue and Forecast to 2027, by Type (US$ Mn)
9.1.8.2.1 Canada Synthetic Superdisintegrants Market, Revenue and Forecast to 2027, by Type (US$ Mn)
9.1.8.3 Canada Superdisintegrants Market, Revenue and Forecast to 2027, by Formulation (US$ Mn)
9.1.8.4 Canada Superdisintegrants Market, Revenue and Forecast to 2027, By Therapeutic Area (US$ Mn)
9.1.9 Mexico
9.1.9.1 Mexico Superdisintegrants Market, Revenue and Forecast to 2027 (US$ Mn)
9.1.9.2 Mexico Superdisintegrants Market, Revenue and Forecast to 2027, by Type (US$ Mn)
9.1.9.2.1 Mexico Synthetic Superdisintegrants Market, Revenue and Forecast to 2027, by Type (US$ Mn)
9.1.9.3 Mexico Superdisintegrants Market, Revenue and Forecast to 2027, by Formulation (US$ Mn)
9.1.9.4 Mexico Superdisintegrants Market, Revenue and Forecast to 2027, By Therapeutic Area (US$ Mn)
10. North America Superdisintegrants Market- Industry Landscape
10.1 Overview
11. Superdisintegrants Market–Key Company Profiles
11.1 Epigenomics AG
11.2 Ashland
11.2.1 Key Facts
11.2.2 Business Description
11.2.3 Products and Services
11.2.4 Financial Overview
11.2.5 SWOT Analysis
11.2.6 Key Developments
11.3 Asahi Kasei Corporation
11.3.1 Key Facts
11.3.2 Business Description
11.3.3 Products and Services
11.3.4 Financial Overview
11.3.5 SWOT Analysis
11.3.6 Key Developments
11.4 Avantor, Inc.
11.4.1 Key Facts
11.4.2 Business Description
11.4.3 Products and Services
11.4.4 Financial Overview
11.4.5 SWOT Analysis
11.4.6 Key Developments
11.5 BASF SE
11.5.1 Key Facts
11.5.2 Business Description
11.5.3 Products and Services
11.5.4 Financial Overview
11.5.5 SWOT Analysis
11.5.6 Key Developments
11.6 Corel Pharma Chem
11.6.1 Key Facts
11.6.2 Business Description
11.6.3 Products and Services
11.6.4 Financial Overview
11.6.5 SWOT Analysis
11.6.6 Key Developments
11.7 Dow DuPont Inc.
11.7.1 Key Facts
11.7.2 Business Description
11.7.3 Products and Services
11.7.4 Financial Overview
11.7.5 SWOT Analysis
11.7.6 Key Developments
11.8 DFE Pharma
11.8.1 Key Facts
11.8.2 Business Description
11.8.3 Financial Overview
11.8.4 Product Portfolio
11.8.5 SWOT Analysis
11.8.6 Key Developments
11.9 JRS Pharma
11.9.1 Key Facts
11.9.2 Business Description
11.9.3 Products and Services
11.9.4 Financial Overview
11.9.5 SWOT Analysis
11.9.6 Key Developments
11.10 MERCK KGAA
11.10.1 Key Facts
11.10.2 Business Description
11.10.3 Products and Services
11.10.4 Financial Overview
11.10.5 SWOT Analysis
11.10.6 Key Developments
11.11 Roquette Frères
11.11.1 Key Facts
11.11.2 Business Description
11.11.3 Products and Services
11.11.4 Financial Overview
11.11.5 SWOT Analysis
11.11.6 Key Developments
12. Appendix
12.1 About The Insight Partners
12.2 Glossary of Terms
LIST OF TABLES
Table 1. North America Superdisintegrants Market, Revenue and Forecast to 2027, By Type (US$ Mn)
Table 2. North America Synthetic Superdisintegrants Market, Revenue and Forecast to 2027, By Type (US$ Mn)
Table 3. North America Superdisintegrants Market, Revenue and Forecast to 2027, By Formulation (US$ Mn)
Table 4. North America Superdisintegrants Market, Revenue and Forecast to 2027, By Therapeutic Area (US$ Mn)
Table 5. North America Superdisintegrants Market, Revenue and Forecast to 2027, By Type (US$ Mn)
Table 6. North America Synthetic Superdisintegrants Market, Revenue and Forecast to 2027, By Type (US$ Mn)
Table 7. North America Superdisintegrants Market, Revenue and Forecast to 2027, By Formulation (US$ Mn)
Table 8. North America Superdisintegrants Market, Revenue and Forecast to 2027, By Therapeutic Area (US$ Mn)
Table 9. US Superdisintegrants Market, Revenue and Forecast to 2027, By Type (US$ Mn)
Table 10. US Synthetic Superdisintegrants Market, Revenue and Forecast to 2027, By Type (US$ Mn)
Table 11. US Superdisintegrants Market, Revenue and Forecast to 2027, By Formulation (US$ Mn)
Table 12. US Superdisintegrants Market, Revenue and Forecast to 2027, By Therapeutic Area (US$ Mn)
Table 13. Canada Superdisintegrants Market, Revenue and Forecast to 2027, By Type (US$ Mn)
Table 14. Canada Synthetic Superdisintegrants Market, Revenue and Forecast to 2027, By Type (US$ Mn)
Table 15. Canada Superdisintegrants Market, Revenue and Forecast to 2027, By Formulation (US$ Mn)
Table 16. Canada Superdisintegrants Market, Revenue and Forecast to 2027, By Therapeutic Area (US$ Mn)
Table 17. Mexico Superdisintegrants Market, Revenue and Forecast to 2027, By Type (US$ Mn)
Table 18. Mexico Synthetic Superdisintegrants Market, Revenue and Forecast to 2027, By Type (US$ Mn)
Table 19. Mexico Superdisintegrants Market, Revenue and Forecast to 2027, By Formulation (US$ Mn)
Table 20. Mexico Superdisintegrants Market, Revenue and Forecast to 2027, By Therapeutic Area (US$ Mn)
Table 21. Recent Organic Growth Strategies in the Superdisintegrants Market
Table 22. Glossary of Terms, Superdisintegrants Market
LIST OF FIGURES
Figure 1. Superdisintegrants Market Segmentation
Figure 2. North America Superdisintegrants Market Overview
Figure 3. Diagnosis Type Segment Held Largest Share Of Modality Segment In Superdisintegrants Market
Figure 4. US Is Expected To Show Remarkable Growth During The Forecast Period
Figure 5. North America Superdisintegrants Market- Leading Country Markets (US$ Mn)
Figure 6. Research Methodology
Figure 7. Superdisintegrants Market - North America PEST Analysis
Figure 8. Superdisintegrants Market Impact Analysis of Drivers And Restraints
Figure 9. North America Superdisintegrants Market – Revenue Forecasts and Analysis – 2019- 2027
Figure 10. Market Positioning Of Key Player In North America Superdisintegrants Market
Figure 11. North America Superdisintegrants Market, by Type 2019 & 2027 (%)
Figure 12. North America Synthetic Superdisintegrants Market Revenue and Forecast to 2027 (US$ Mn)
Figure 13. North America Crospovidone Market Revenue and Forecast to 2027 (US$ Mn)
Figure 14. North America Modified Starch Market Revenue and Forecast to 2027 (US$ Mn)
Figure 15. North America Modified Cellulose Market Revenue and Forecast to 2027 (US$ Mn)
Figure 16. North America Calcium Silicates Market Revenue and Forecast to 2027 (US$ Mn)
Figure 17. North America Ion Exchange Resins Market Revenue and Forecast to 2027 (US$ Mn)
Figure 18. North America Natural Superdisintegrants Market Revenue and Forecast to 2027 (US$ Mn)
Figure 19. North America Other Superdisintegrants Market Revenue and Forecast to 2027 (US$ Mn)
Figure 20. North America Superdisintegrants Market, by Formulation 2019 & 2027 (%)
Figure 21. North America Tablets Market Revenue And Forecast To 2027 (US$ Mn)
Figure 22. North America Capsules Market Revenue And Forecast To 2027 (US$ Mn)
Figure 23. North America Superdisintegrants Market, by Therapeutic Area 2019 & 2027 (%)
Figure 24. North America Neurological Diseases Market Revenue And Forecast To 2027 (US$ Mn)
Figure 25. North America Gastrointestinal Market Revenue And Forecast To 2027 (US$ Mn)
Figure 26. North America Oncology Market Revenue And Forecast To 2027 (US$ Mn)
Figure 27. North America Inflammatory Diseases Market Revenue And Forecast To 2027 (US$ Mn)
Figure 28. North America Infectious Diseases Market Revenue And Forecast To 2027 (US$ Mn)
Figure 29. North America Cardiovascular Diseases Market Revenue And Forecast To 2027 (US$ Mn)
Figure 30. North America Others Market Revenue And Forecast To 2027 (US$ Mn)
Figure 31. North America Superdisintegrants Market Revenue Overview, By Country (2018) (US$ Mn)
Figure 32. North America Superdisintegrants Market Revenue and Forecast to 2027 (US$ Mn)
Figure 33. North America Superdisintegrants Market, Revenue and Forecast to 2027, By Country (%)
Figure 34. US Superdisintegrants Market, Revenue and Forecast to 2027 (US$ Mn)
Figure 35. Canada Superdisintegrants Market, Revenue and Forecast to 2027 (US$ Mn)
Figure 36. Mexico Superdisintegrants Market, Revenue and Forecast to 2027 (US$ Mn)
The List of Companies - North America Superdisintegrants Market
- Ashland,
- BASF SE
- DowDupont Inc.
- JRS PHARMA
- COREL PHARMA CHEM
- Roquette Frères
- Asahi Kasei Corporation
- Merck KGaA
- Avantor, Inc.
- DFE Pharma
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the North America superdisintegrants market.
- Highlights key business priorities in order to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in the North America superdisintegrants market, thereby allowing players across the value chain to develop effective long-term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth regional market trends and outlook coupled with the factors driving the market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.